MAPK6 and neoplasm: These findings suggest that ERK3 itself may not be able to transform normal epithelial cells but is capable of promoting tumor growth once cells are transformed and/or tumorigenic following the loss-of-function mutation of tumor suppressor genes (e.g., PTEN) or gain-of-function mutation(s) of oncogenes such as KRASG12 mutations.